These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 27890820)

  • 21. Genetics-directed drug discovery for combating Mycobacterium tuberculosis infection.
    Quan Y; Xiong L; Chen J; Zhang HY
    J Biomol Struct Dyn; 2017 Feb; 35(3):616-621. PubMed ID: 26900080
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined Bioinformatics and Combinatorial Chemistry Tools to Locate Drug-Able Anti-TB Phytochemicals: A Cost-Effective Platform for Natural Product-Based Drug Discovery.
    Swain SS; Hussain T
    Chem Biodivers; 2022 Nov; 19(11):e202200267. PubMed ID: 36307750
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The future for early-stage tuberculosis drug discovery.
    Zuniga ES; Early J; Parish T
    Future Microbiol; 2015; 10(2):217-29. PubMed ID: 25689534
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SAR analysis of new anti-TB drugs currently in pre-clinical and clinical development.
    Poce G; Cocozza M; Consalvi S; Biava M
    Eur J Med Chem; 2014 Oct; 86():335-51. PubMed ID: 25173852
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tuberculosis drug discovery and emerging targets.
    Mdluli K; Kaneko T; Upton A
    Ann N Y Acad Sci; 2014 Sep; 1323():56-75. PubMed ID: 24920100
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tuberculosis Drug Discovery: Challenges and New Horizons.
    Fernandes GFS; Thompson AM; Castagnolo D; Denny WA; Dos Santos JL
    J Med Chem; 2022 Jun; 65(11):7489-7531. PubMed ID: 35612311
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New tuberculosis therapeutics: a growing pipeline.
    Spigelman MK
    J Infect Dis; 2007 Aug; 196 Suppl 1():S28-34. PubMed ID: 17624823
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predicting natural product value, an exploration of anti-TB drug space.
    Dashti Y; Grkovic T; Quinn RJ
    Nat Prod Rep; 2014 Aug; 31(8):990-8. PubMed ID: 24881816
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Isoniazid derivatives and their anti-tubercular activity.
    Hu YQ; Zhang S; Zhao F; Gao C; Feng LS; Lv ZS; Xu Z; Wu X
    Eur J Med Chem; 2017 Jun; 133():255-267. PubMed ID: 28390957
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent advances in the research of heterocyclic compounds as antitubercular agents.
    Yan M; Ma S
    ChemMedChem; 2012 Dec; 7(12):2063-75. PubMed ID: 23042656
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent developments of coumarin-containing derivatives and their anti-tubercular activity.
    Hu YQ; Xu Z; Zhang S; Wu X; Ding JW; Lv ZS; Feng LS
    Eur J Med Chem; 2017 Aug; 136():122-130. PubMed ID: 28494250
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tuberculosis: the drug development pipeline at a glance.
    Villemagne B; Crauste C; Flipo M; Baulard AR; Déprez B; Willand N
    Eur J Med Chem; 2012 May; 51():1-16. PubMed ID: 22421275
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of new antituberculosis drugs from natural products.
    Igarashi M
    Biosci Biotechnol Biochem; 2017 Jan; 81(1):32-37. PubMed ID: 27885931
    [No Abstract]   [Full Text] [Related]  

  • 34. Type-II NADH Dehydrogenase (NDH-2): a promising therapeutic target for antitubercular and antibacterial drug discovery.
    Sellamuthu S; Singh M; Kumar A; Singh SK
    Expert Opin Ther Targets; 2017 Jun; 21(6):559-570. PubMed ID: 28472892
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent developments in genomics, bioinformatics and drug discovery to combat emerging drug-resistant tuberculosis.
    Swaminathan S; Sundaramurthi JC; Palaniappan AN; Narayanan S
    Tuberculosis (Edinb); 2016 Dec; 101():31-40. PubMed ID: 27865394
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Marine natural products as potential anti-tubercular agents.
    Hou XM; Wang CY; Gerwick WH; Shao CL
    Eur J Med Chem; 2019 Mar; 165():273-292. PubMed ID: 30685527
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The anti-tuberculosis agents under development and the challenges ahead.
    Kumar D; Negi B; Rawat DS
    Future Med Chem; 2015; 7(15):1981-2003. PubMed ID: 26505682
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification and validation of novel drug targets in Mycobacterium tuberculosis.
    Singh V; Mizrahi V
    Drug Discov Today; 2017 Mar; 22(3):503-509. PubMed ID: 27649943
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design, synthesis, and structure-activity relationship studies of tryptanthrins as antitubercular agents.
    Hwang JM; Oh T; Kaneko T; Upton AM; Franzblau SG; Ma Z; Cho SN; Kim P
    J Nat Prod; 2013 Mar; 76(3):354-67. PubMed ID: 23360475
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Promising candidates in clinical trials against multidrug-resistant tuberculosis (MDR-TB) based on natural products.
    de Souza MV
    Fitoterapia; 2009 Dec; 80(8):453-60. PubMed ID: 19698768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.